Pfizer on Wednesday announced that a third dose of its mRNA vaccine can protect against the Omicron variant of Covid-19.
Results from an initial laboratory...
US drug maker Pfizer wrongly assumed that the coronavirus outbreak would be quickly contained and thus declined the offer made by BioNTech to develop...
Riding on the success of its Covid vaccine, US bio-pharmaceutical company Pfizer anticipates to make revenues of approximately $33.5 billion in 2021, up from...
US President Joe Biden's administration plans to buy 500 million doses of the Pfizer-BioNTech Covid-19 vaccine and donate them among about 100 countries over...
US pharmaceutical company Pfizer has begun Phase 1 clinical trial of a novel oral antiviral drug for SARS-CoV-2, the virus that causes Covid-19.
The oral...